cyamemazine

This page covers all cyamemazine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2C.

Targets

5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2C

Phase 2 pipeline (1)

• Ciamatil · Other
  Ciamatil works by blocking the 5-HT2A receptor, a protein that helps regulate mood and other psychological processes.

Patent intelligence

• cyamemazine patent landscape — aggregated cliff calendar, attackable patents, originator estates